Department of Pediatrics: Where Clinical Care and Research Intersect to Enhance Child and Family Health
The Department excels in clinical care, education and in leading pioneering research initiatives. Our team of over #? of researchers including ten (10) tenured clinician-scientists, six (6) PhD scientists, and 15 FRQS-funded clinician-scientists*, are driving forward significant advancements in child health research. This synergy between clinical care and research highlights our commitment to enhancing outcomes for children and families.
Simon Lafontaine |
|
|
|
My research explores the challenges adolescents with type 1 diabetes face as they transition from pediatric to adult care. As emerging adults gain autonomy in managing their diabetes and transfer to adult care, they encounter unique age-specific barriers that must be addressed by their healthcare providers to ensure a smooth and successful transition.聽 Under the supervision of Dr. Meranda Nakhla, I examine health outcomes during the transition period to identify gaps in care and healthcare needs of young adults with diabetes. By informing the design and delivery of transition care services, my research ultimately aims to improve the transition process as well as long-term diabetes management. The intersection of clinical care and research is central to my vision of medicine. As an incoming 91社区 Internal Medicine resident, I plan to continue my research with a focus on optimizing health service delivery models for adults with childhood-onset chronic diseases. |
Dr. Mallory Downie |
|
 |
My research program is focused on identifying new genes and genetic risk factors in childhood kidney disease using bioinformatics. Currently, I am studying childhood nephrotic syndrome which is caused by injury to the tiny filters inside the kidney. When these filters are injured, the kidney leaks protein from the blood into the urine, causing a child's body to swell. If left untreated, children with nephrotic syndrome can develop infections, blood clots, and can die. Genes and genetic risk variants associated with nephrotic syndrome can help us understand why the disease develop in the first place. They can also provide drug targets for new treatments and may someday be used in the clinic to predict the development or severity of the disease. My research career is inspired by my clinical care of children who have serious kidney disease and no identified cause. I want to use genetics to help prevent, delay, prognose, and treat their diseases. |
Dr. Loydie Jerome-Majewska |
|
 |
Testimonial coming soon... |
